Stem cell therapy for ischemic heart disease

Rutger J. Hassink*, Joshua D. Dowell, Aart Brutel De la Rivière, Pieter A. Doevendans, Loren J. Field

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Recent experimental and clinical observations have suggested that cell transplantation could be of therapeutic value for the treatment of heart disease. This approach was based on the idea that transplanted donor cardiomyocytes would integrate with the host myocardium and thereby directly contribute to cardiac function. Surprisingly, the observation that non-cardiomyogenic cells could also improve cardiac function indicates that functional integration of donor cells might not be required to achieve a beneficial effect. More recently, several observations have suggested the presence of a greater than anticipated developmental repertoire in adult-derived stem cells, which, if further validated, would offer unprecedented opportunities for the restoration of cardiac function in diseased hearts. Here, we discuss current issues regarding the potential use of stem cell transplantation for the treatment of ischemic heart disease.

Original languageEnglish
Pages (from-to)436-441
Number of pages6
JournalTrends in molecular medicine
Volume9
Issue number10
DOIs
Publication statusPublished - Oct 2003

Keywords

  • Econometric and Statistical Methods: General
  • Geneeskunde(GENK)
  • Bescherming en bevordering van de menselijke gezondheid
  • Other medical specialities

Fingerprint

Dive into the research topics of 'Stem cell therapy for ischemic heart disease'. Together they form a unique fingerprint.

Cite this